Surmodics, Inc. - stock earnings
SRDX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -786000 USD | 30.6 million USD |
| 2023Q3 | 6.7 million USD | 28.0 million USD |
| 2023Q2 | 7.3 million USD | 52.5 million USD |
| 2023Q1 | -7.7 million USD | 27.2 million USD |
| 2022Q4 | -7.8 million USD | 24.9 million USD |
| 2022Q3 | -14.7 million USD | 26.0 million USD |
| 2022Q2 | -5.7 million USD | 24.9 million USD |
| 2022Q1 | -4.1 million USD | 26.1 million USD |
| 2021Q4 | -2.8 million USD | 23.0 million USD |
| 2021Q3 | -289000 USD | 24.0 million USD |
| 2021Q2 | -3.3 million USD | 23.9 million USD |
| 2021Q1 | 8.1 million USD | 35.0 million USD |
| 2020Q4 | -274000 USD | 22.3 million USD |
| 2020Q3 | -2.9 million USD | 22.5 million USD |
| 2020Q2 | 2.5 million USD | 26.9 million USD |
| 2020Q1 | 1.5 million USD | 22.8 million USD |
| 2019Q4 | 148000 USD | 22.6 million USD |
| 2019Q3 | 3.6 million USD | 30.8 million USD |
| 2019Q2 | 1.5 million USD | 24.3 million USD |
| 2019Q1 | 1.3 million USD | 22.7 million USD |
| 2018Q4 | 1.3 million USD | 22.2 million USD |
| 2018Q3 | -1.8 million USD | 23.0 million USD |
| 2018Q2 | -2.7 million USD | 22.2 million USD |
| 2018Q1 | 1.5 million USD | 19.1 million USD |
| 2017Q4 | -1.6 million USD | 17.0 million USD |
| 2017Q3 | 400000 USD | 20.1 million USD |
| 2017Q2 | 720000 USD | 17.8 million USD |
| 2017Q1 | 506000 USD | 17.5 million USD |
| 2016Q4 | 2.3 million USD | 17.8 million USD |
| 2016Q3 | 2.6 million USD | 18.2 million USD |
| 2016Q2 | 4.0 million USD | 20.0 million USD |
| 2016Q1 | 825000 USD | 16.7 million USD |
| 2015Q4 | 2.5 million USD | 16.5 million USD |
| 2015Q3 | 2.9 million USD | 17.4 million USD |
| 2015Q2 | 3.9 million USD | 15.9 million USD |
| 2015Q1 | 3.1 million USD | 14.4 million USD |
| 2014Q4 | 3.6 million USD | 14.2 million USD |
| 2014Q3 | 2.3 million USD | 15.3 million USD |
| 2014Q2 | 3.6 million USD | 14.6 million USD |
| 2014Q1 | 2.5 million USD | 13.6 million USD |
| 2013Q4 | 3.6 million USD | 13.9 million USD |
| 2013Q3 | 3.7 million USD | 14.3 million USD |
| 2013Q2 | 3.1 million USD | 14.3 million USD |
| 2013Q1 | 4.1 million USD | 13.7 million USD |
| 2012Q4 | 4.2 million USD | 13.9 million USD |
| 2012Q3 | 2.7 million USD | 13.8 million USD |
| 2012Q2 | 3.1 million USD | 14.0 million USD |
| 2012Q1 | 1.7 million USD | 12.2 million USD |
| 2011Q4 | 2.7 million USD | 11.9 million USD |
| 2011Q3 | -12.9 million USD | 17.2 million USD |
| 2011Q2 | 3.8 million USD | 18.0 million USD |
| 2011Q1 | 2.5 million USD | 17.5 million USD |
| 2010Q4 | -377000 USD | 15.2 million USD |
| 2010Q3 | -21.7 million USD | 15.5 million USD |
| 2010Q2 | -916000 USD | 18.6 million USD |
| 2010Q1 | -427000 USD | 18.4 million USD |
| 2009Q4 | 1.9 million USD | 17.4 million USD |
| 2009Q3 | 2.7 million USD | 19.2 million USD |
| 2009Q2 | 3.5 million USD | 18.2 million USD |
| 2009Q1 | 4.2 million USD | 20.9 million USD |
| 2008Q4 | 27.1 million USD | 63.2 million USD |
| 2008Q3 | -814000 USD | 23.2 million USD |
| 2008Q2 | 4.8 million USD | 24.3 million USD |
| 2008Q1 | 5.1 million USD | 25.7 million USD |
| 2007Q4 | 5.6 million USD | 23.8 million USD |
| 2007Q3 | -13.9 million USD | 21.3 million USD |
| 2007Q2 | 5.6 million USD | 17.8 million USD |
| 2007Q1 | 5.7 million USD | 17.4 million USD |
| 2006Q4 | 6.0 million USD | 16.7 million USD |
| 2006Q3 | 6.3 million USD | 17.6 million USD |
| 2006Q2 | 6.4 million USD | 18.1 million USD |
| 2006Q1 | 1.5 million USD | 17.7 million USD |
| 2005Q4 | 6.2 million USD | 16.5 million USD |
| 2005Q3 | 4.8 million USD | 16.1 million USD |
| 2005Q2 | 6.1 million USD | 16.5 million USD |
| 2005Q1 | -24.4 million USD | 15.7 million USD |
| 2004Q4 | 5.7 million USD | 14.1 million USD |
| 2004Q3 | 5.4 million USD | 13.5 million USD |
| 2004Q2 | -6.5 million USD | 11.4 million USD |
| 2004Q1 | 4.4 million USD | 12.7 million USD |
| 2003Q4 | 4.1 million USD | 12.1 million USD |
| 2003Q3 | 4.4 million USD | 12.6 million USD |
| 2003Q2 | 4.6 million USD | 12.8 million USD |
| 2003Q1 | 2.8 million USD | 9.7 million USD |
| 2002Q4 | 2.2 million USD | 8.0 million USD |
| 2002Q3 | 2.6 million USD | 8.7 million USD |
| 2002Q2 | 2.0 million USD | 7.6 million USD |
| 2002Q1 | 1.8 million USD | 7.1 million USD |
| 2001Q4 | 1.4 million USD | 6.1 million USD |
| 2001Q3 | 559000 USD | 6.9 million USD |
| 2001Q2 | 1.6 million USD | 5.6 million USD |
| 2001Q1 | 1.6 million USD | 5.4 million USD |
| 2000Q4 | 1.4 million USD | 4.8 million USD |
| 2000Q3 | 1.5 million USD | 5.5 million USD |
| 2000Q2 | 861000 USD | 4.2 million USD |
| 2000Q1 | 904000 USD | 4.4 million USD |
| 1999Q4 | 900000 USD | 4.1 million USD |
| 1999Q3 | 1.2 million USD | 3.9 million USD |
| 1999Q2 | 1.2 million USD | 3.7 million USD |
| 1999Q1 | 1.1 million USD | 3.3 million USD |
| 1998Q4 | 900000 USD | 2.6 million USD |
| 1998Q3 | 500000 USD | 2.6 million USD |
| 1998Q2 | 600000 USD | 2.7 million USD |
| 1998Q1 | 400000 USD | 2.6 million USD |
| 1997Q4 | 100000 USD | 1.9 million USD |
SRDX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -1.5 million USD | 132.6 million USD |
| 2022 | -27.3 million USD | 100.0 million USD |
| 2021 | 4.2 million USD | 105.1 million USD |
| 2020 | 1.1 million USD | 94.9 million USD |
| 2019 | 7.6 million USD | 100.1 million USD |
| 2018 | -4.5 million USD | 81.3 million USD |
| 2017 | 3.9 million USD | 73.1 million USD |
| 2016 | 10.0 million USD | 71.4 million USD |
| 2015 | 13.4 million USD | 61.9 million USD |
| 2014 | 12.0 million USD | 57.4 million USD |
| 2013 | 15.2 million USD | 56.1 million USD |
| 2012 | 10.2 million USD | 51.9 million USD |
| 2011 | -12.8 million USD | 67.8 million USD |
| 2010 | -21.1 million USD | 69.9 million USD |
| 2009 | 37.6 million USD | 121.5 million USD |
| 2008 | 14.7 million USD | 97.1 million USD |
| 2007 | 3.3 million USD | 73.2 million USD |
| 2006 | 20.3 million USD | 69.9 million USD |
| 2005 | -8.2 million USD | 62.4 million USD |
| 2004 | 7.4 million USD | 49.7 million USD |
| 2003 | 13.9 million USD | 43.2 million USD |
| 2002 | 7.8 million USD | 29.5 million USD |
| 2001 | 5.1 million USD | 22.7 million USD |
| 2000 | 4.2 million USD | 18.3 million USD |
| 1999 | 4.4 million USD | 13.5 million USD |
| 1998 | 1.6 million USD | 9.8 million USD |
SRDX
Price: $26.17
52 week price:
Earnings Per Share: 0.39 USD
P/E Ratio: 79.85
Exchange: NMS
Sector: Healthcare
Industry: Medical Devices
Volume: 34922
Ebitda: 887000Market Capitalization: 390.9 million